Your browser doesn't support javascript.
loading
Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care.
Lee, Joseph Jonathan; Smith, Margaret; Bankhead, Clare; Perera Salazar, Rafael; Kousoulis, Antonis A; Butler, Christopher C; Wang, Kay.
Afiliação
  • Lee JJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK joseph.lee@phc.ox.ac.uk.
  • Smith M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Bankhead C; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Perera Salazar R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Kousoulis AA; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Wang K; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Eur Respir J ; 56(5)2020 11.
Article em En | MEDLINE | ID: mdl-32527739
ABSTRACT

BACKGROUND:

Influenza and influenza-like illness (ILI) place considerable burden on healthcare systems, especially during influenza epidemics and pandemics. During the 2009/10 H1N1 influenza pandemic, UK national guidelines recommended antiviral medications for patients presenting within 72 h of ILI onset. However, it is not clear whether antiviral treatment was associated with reductions in influenza-related complications.

METHODS:

Our study population consisted of a retrospective cohort of children aged ≤17 years who presented with influenza/ILI at UK primary care practices contributing to the Clinical Practice Research Datalink during the 2009/10 pandemic. We used doubly robust inverse-probability weighted propensity scores and physician prior prescribing instrumental variable methods to estimate the causal effect of oseltamivir prescribing on influenza-related complications. Secondary outcomes were complications requiring intervention, pneumonia, pneumonia or hospitalisation, influenza-related hospitalisation and all-cause hospitalisation.

RESULTS:

We included 16 162 children, of whom 4028 (24.9%) were prescribed oseltamivir, and 753 (4.7%) had recorded complications. Under propensity score analyses oseltamivir prescriptions were associated with reduced influenza-related complications (risk difference (RD) -0.015, 95% CI -0.022--0.008), complications requiring further intervention, pneumonia, pneumonia or hospitalisation and influenza-related hospitalisation, but not all-cause hospitalisation. Adjusted instrumental variable analyses estimated reduced influenza-related complications (RD -0.032, 95% CI -0.051--0.013), pneumonia or hospitalisation, all-cause and influenza-related hospitalisations.

CONCLUSIONS:

Based on causal inference analyses of observational data, oseltamivir treatment in children with influenza/ILI was associated with a small but statistically significant reduction in influenza-related complications during an influenza pandemic.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Influenza Humana / Vírus da Influenza A Subtipo H1N1 Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Influenza Humana / Vírus da Influenza A Subtipo H1N1 Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Revista: Eur Respir J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido